Hypomethylating Agents

Hypomethylating Agents is a class of epigenetic therapeutic agents that function by inhibiting DNA methyltransferases, thereby reducing aberrant DNA hypermethylation associated with gene silencing in myelodysplastic syndromes.

458

Publications

32.2K

Citations

3.5K

Authors

1.1K

Institutions

Publications per year

2017–2026

218

Variants

Dna Methyltransferase InhibitorsDnmt InhibitorsHypomethylating Drugs

Authors

3.5K

  1. GG
    Guillermo Garcia‐Manero

    The University of Texas MD Anderson Cancer Center, United States

    62 publications · 6.5K citations

    38

    h-index

  2. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    52 publications · 7.2K citations

    35

    h-index

  3. FR
    Farhad Ravandi

    The University of Texas MD Anderson Cancer Center, United States

    39 publications · 4.7K citations

    32

    h-index

  4. EJ
    Elias Jabbour

    The University of Texas MD Anderson Cancer Center, United States

    29 publications · 2K citations

    22

    h-index

  5. MK
    Marina Konopleva

    The University of Texas MD Anderson Cancer Center, United States

    22 publications · 4.4K citations

    19

    h-index

1–5 of 3.5K

Venues

  1. Blood

    36 publications · 3.2K citations

    22

    h-index

  2. Cancer

    16 publications · 3K citations

    16

    h-index

  3. Leukemia & lymphoma/Leukemia and lymphoma

    23 publications · 745 citations

    16

    h-index

  4. PubMed

    Repository · 24 publications · 877 citations

    16

    h-index

  5. Blood Advances

    15 publications · 978 citations

    15

    h-index

1–5